NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

內臟痛治療市場:各藥物類型、適應症、流通管道、地區的市場規模、佔有率、預測 - COVID-19的影響分析 (2021-2027年)

Visceral Pain Treatment Market with COVID-19 Impact Analysis, By Drug Type, By Indication, By Distribution Channel, and By Region - Size, Share, & Forecast from 2021-2027

出版商 AnalystView Market Insights 商品編碼 980688
出版日期 內容資訊 英文 240 Pages
商品交期: 2-3個工作天內
價格
內臟痛治療市場:各藥物類型、適應症、流通管道、地區的市場規模、佔有率、預測 - COVID-19的影響分析 (2021-2027年) Visceral Pain Treatment Market with COVID-19 Impact Analysis, By Drug Type, By Indication, By Distribution Channel, and By Region - Size, Share, & Forecast from 2021-2027
出版日期: 2020年12月01日內容資訊: 英文 240 Pages
簡介

全球內臟痛治療的市場規模,2020年價值126億美元,預計從2021年到2027年的預測期間內以5.9%的年複合成長率成長。

內臟痛治療市場,由於醫藥品企業對開發新藥的投資增加,今後數年預計大幅度成長。再加上腸症候群的優勢的高漲,預計推動市場成長。根據International Foundation of Gastrointestinal Disorder(IFFGD),年度成人約有10∼15%罹患腸症候群。

本報告提供全球內臟痛治療市場相關調查分析,市場概要,市場規模與預測,各市場區隔的市場分析,各地區的市場分析,競爭情形等相關的系統性資訊。

目錄

第1章 內臟痛治療的市場概要

第2章 摘要整理

  • 市場明細
    • 市場明細:各藥物類型
    • 市場明細:各適應症
    • 市場明細:各流通管道
    • 市場明細:各地區
  • 競爭考察

第3章 內臟痛治療主要的市場趨勢

  • 促進市場成長因素
    • 市場成長要素的影響分析
  • 阻礙市場要素
    • 阻礙市場要素的影響分析
  • 市場機會
  • 市場未來趨勢

第4章 內臟痛治療產業的調查

  • 波特的五力分析
  • 行銷策略分析
  • 成長展望製圖
  • 法律規範分析

第5章 內臟痛治療市場:COVID-19的影響分析

  • COVID-19前的影響分析
  • COVID-19後的影響分析
    • 最高效能市場區隔
    • 邊際成長市場區隔
    • Top Looser市場區隔
    • 邊際損失市場區隔

第6章 內臟痛治療:市場形勢

  • 市場佔有率分析
  • 主要的創新者分析
  • 明細資料:各主要製造商
    • 現有企業分析
    • 新興企業分析

第7章 內臟痛治療市場:各藥物類型

  • 概要
  • 疼痛調整劑
  • 止痛藥

第8章 內臟痛治療市場:各適應症

  • 概要
  • 慢性前列腺炎
  • 克隆氏症
  • 間質性膀胱炎
  • 潰瘍性大腸炎

第9章 行動POS(mPOS)終端市場:各流通管道

  • 概要
  • 醫院藥局
  • 零售藥局
  • 線上

第10章 內臟痛治療市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區(APAC)
  • 南美
  • 中東、非洲

第11章 供應商分析

  • 競爭儀表板
  • 企業簡介
    • AstraZeneca
    • Addex Therapeutics Ltd.
    • Astellas Pharma Inc.
    • Abbvie
    • Allergan
    • Bayer AG
    • Pfizer, Inc.
    • Chromocell Corporation
    • GIcare Pharma Inc.
    • Johnson & Johnson
    • Neurim Pharmaceuticals Ltd
    • Takeda
    • Medestea Research & Production S.p.A.
    • Grunenthal GmbH

第12章 分析師全方位展望

第13章 附錄

目錄

REPORT HIGHLIGHT

The global visceral pain treatment market was valued at USD 12.6 billion in 2020, growing with 5.9% CAGR during the forecast period, 2021-2027.

The visceral pain is caused by inflammation of organs including the stomach, bladder, rectum, and uterus. The inflammation is occurred due to trauma, infection, and other injuries in internal organs. The visceral pain market is adversely affected by the COVID-19 outbreak. Several players are focusing on clinical trials, and R& D activities to develop new drugs.

The visceral pain treatment market is anticipated to witness significant growth in the next few years, owing to the increase in investment by pharmaceutical companies to develop novel drugs. In addition, a rising predominance of bowel syndrome is projected to boost the market growth. According to the International Foundation of Gastrointestinal Disorder (IFFGD), around 10-15% of adults suffer from bowel syndrome per year.

The rising number of clinical trial activities and high spending on R&D is expected to drive the growth of visceral pain treatment. The higher number of drug approvals is projected to offer potential growth opportunities for the market. For example, Ironwood Pharmaceuticals Inc. has received the approval of 'LINZESS' of strength 145 mcg, 72 mcg, and 290 mcg in China market for treating patients with bowel syndrome. AstraZeneca and Ironwood Pharmaceuticals have together developed LINZESS drugs to treat visceral pain issues. These initiatives are anticipated to bolster market growth over the forecast period.

North America held the highest market share in 2019. The presence of key players and growing focus on R&D development in novel drugs is boosting regional growth. Further, the increasing prevalence of Crohn's Disease, bowel syndrome is primarily contributing to market growth. According to the data of Gastroenterology and Hepatology Journal, around 400 to 600 cases are registered with Crohn's disease per 100,000 people. Thus, the region is estimated to remain at its leading position during the forecast period. Furthermore, the rising prevalence of visceral pain diseases in the Asia Pacific is expected to significantly boost the market growth. Additionally, growing healthcare investments and development by pharmaceutical companies in the medical sector across the developing countries are also supporting the market growth.

The visceral pain treatment market is highly fragmented with the presence of international and local players. Key players in the market are dominating with the largest market share. Several players in the market engage in new product developments, strategic collaborations to enhance their product portfolio. For example, in 2020, the Novartis and Drugs for Neglected Diseases initiative (DNDi) have collaborated to develop a drug called LXE408 which is used for visceral pain treatment.

Key features of the study:

This proposed research study on Visceral Pain Treatment market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2020-2027), considering 2019 as the base year

The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Visceral Pain Treatment market

The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Visceral Pain Treatment market

Impact of COVID-19 on Visceral Pain Treatment market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Visceral Pain Treatment market post-COVID will also be covered.

In order to give the users of this report a comprehensive view on the Visceral Pain Treatment market, we have also included competitive landscape and key innovator analysis for the Visceral Pain Treatment market.

The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and end-user's attractiveness.

The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Visceral Pain Treatment market.

In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new product launch, research & development, regional expansion of major participants involved in the Visceral Pain Treatment market on global as well as regional level.

The global Visceral Pain Treatment market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL VISCERAL PAIN TREATMENT MARKET KEY PLAYERS

AstraZeneca

Addex Therapeutics Ltd.

Astellas Pharma Inc.

Abbvie

Allergan

Bayer AG

Pfizer, Inc.

Chromocell Corporation

GIcare Pharma Inc.

Johnson & Johnson

Neurim Pharmaceuticals Ltd

Takeda

Medestea Research & Production S.p.A.

Grunenthal GmbH

GLOBAL VISCERAL PAIN TREATMENT MARKET, BY DRUG TYPE

Pain Modifiers

Tricyclic Antidepressants

Tricyclic Anticonvulsant

Analgesics

NSAID

Narcotics

Others

GLOBAL VISCERAL PAIN TREATMENT MARKET, BY INDICATION

Chronic Prostatitis

Crohn's Disease

Interstitial Cystitis

Ulcerative Colitis

GLOBAL VISCERAL PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL

Hospital Pharmacies

Retail Pharmacies

Online

GLOBAL VISCERAL PAIN TREATMENT MARKET, BY REGION

North America

The U.S.

Canada

Europe

Germany

France

Italy

Spain

United Kingdom

Rest of Europe

Asia Pacific

India

China

South Korea

Japan

Singapore

Rest of APAC

Latin America

Brazil

Mexico

Argentina

Rest of LATAM

The Middle East and Africa

Saudi Arabia

United Arab Emirates

Rest of MEA

TABLE OF CONTENT

1. Visceral Pain Treatment Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Market Snippet by Drug Type
    • 2.1.2. Market Snippet by Indication
    • 2.1.3. Market Snippet by Distribution Channel
    • 2.1.4. Market Snippet by Region
  • 2.2. Competitive Insights

3. Visceral Pain Treatment Key Market Trends

  • 3.1. Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Future Trends

4. Visceral Pain Treatment Industry Study

  • 4.1. Porter's Five Forces Analysis
  • 4.2. Marketing Strategy Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Visceral Pain Treatment Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Visceral Pain Treatment Market Landscape

  • 6.1. Market Share Analysis, 2019
  • 6.2. Key Innovators Analysis
  • 6.3. Breakdown Data, by Key Manufacturer
    • 6.3.1. Established Players' Analysis
    • 6.3.2. Emerging Players' Analysis

7. Visceral Pain Treatment Market - By Drug Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Drug Type, 2020 & 2027 (%)
  • 7.2. Pain Modifiers
    • 7.2.1. Tricyclic Antidepressants
    • 7.2.2. Tricyclic Anticonvulsant
  • 7.3. Analgesics
    • 7.3.1. NSAID
    • 7.3.2. Narcotics
  • 7.4. Others

8. Visceral Pain Treatment Market - By Indication

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Indication, 2020 & 2027 (%)
  • 8.2. Chronic Prostatitis
  • 8.3. Crohn's Disease
  • 8.4. Interstitial Cystitis
  • 8.5. Ulcerative Colitis

9. Visceral Pain Treatment Market - By Distribution Channel

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution Channel, 2020 & 2027 (%)
  • 9.2. Hospital Pharmacies
  • 9.3. Retail Pharmacies
  • 9.4. Online

10. Visceral Pain Treatment Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2020 & 2027 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Indication, 2016 - 2027 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Indication, 2016 - 2027 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Indication, 2016 - 2027 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Indication, 2016 - 2027 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Indication, 2016 - 2027 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Indication, 2016 - 2027 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Indication, 2016 - 2027 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Indication, 2016 - 2027 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 10.3.11. Rest of Europe
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 10.3.11.3. Rest of the Europe Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
      • 10.3.11.4. Rest of the Europe Market Size and Forecast, By Indication, 2016 - 2027 (US$ Million)
      • 10.3.11.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Indication, 2016 - 2027 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Indication, 2016 - 2027 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Indication, 2016 - 2027 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Indication, 2016 - 2027 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Indication, 2016 - 2027 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 10.4.11. Rest of APAC
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 10.4.11.3. Rest of APAC Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
      • 10.4.11.4. Rest of APAC Market Size and Forecast, By Indication, 2016 - 2027 (US$ Million)
      • 10.4.11.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Indication, 2016 - 2027 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Indication, 2016 - 2027 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Indication, 2016 - 2027 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Indication, 2016 - 2027 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 10.5.10. Rest of LATAM
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 10.5.10.3. Rest of LATAM Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
      • 10.5.10.4. Rest of LATAM Market Size and Forecast, By Indication, 2016 - 2027 (US$ Million)
      • 10.5.10.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Indication, 2016 - 2027 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Indication, 2016 - 2027 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Indication, 2016 - 2027 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Indication, 2016 - 2027 (US$ Million)

11. Key Vendor Analysis

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. AstraZeneca
    • 11.2.2. Addex Therapeutics Ltd.
    • 11.2.3. Astellas Pharma Inc.
    • 11.2.4. Abbvie
    • 11.2.5. Allergan
    • 11.2.6. Bayer AG
    • 11.2.7. Pfizer, Inc.
    • 11.2.8. Chromocell Corporation
    • 11.2.9. GIcare Pharma Inc.
    • 11.2.10. Johnson & Johnson
    • 11.2.11. Neurim Pharmaceuticals Ltd
    • 11.2.12. Takeda
    • 11.2.13. Medestea Research & Production S.p.A.
    • 11.2.14. Grunenthal GmbH

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Visceral Pain Treatment market: Drug Types Snapshot (2019)
  • TABLE Segment Dashboard; Definition and Scope, by Drug Types
  • TABLE Global Visceral Pain Treatment market, by Drug Types 2016-2027 (USD Million)
  • TABLE Visceral Pain Treatment market: Indication Snapshot (2019)
  • TABLE Segment Dashboard; Definition and Scope, by Indication
  • TABLE Global Visceral Pain Treatment market, by Indication 2016-2027 (USD Million)
  • TABLE Visceral Pain Treatment market: Regional snapshot (2019)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Visceral Pain Treatment market, by Region 2016-2027 (USD Million)
  • TABLE North America Visceral Pain Treatment market, by Country, 2016-2027 (USD Million)
  • TABLE North America Visceral Pain Treatment market, by Drug Types, 2016-2027 (USD Million)
  • TABLE North America Visceral Pain Treatment market, by Indication, 2016-2027 (USD Million)
  • TABLE Europe Visceral Pain Treatment market, by Country, 2016-2027 (USD Million)
  • TABLE Europe Visceral Pain Treatment market, by Drug Types, 2016-2027 (USD Million)
  • TABLE Europe Visceral Pain Treatment market, by Indication, 2016-2027 (USD Million)
  • TABLE Asia Pacific Visceral Pain Treatment market, by Country, 2016-2027 (USD Million)
  • TABLE Asia Pacific Visceral Pain Treatment market, by Drug Types, 2016-2027 (USD Million)
  • TABLE Asia Pacific Visceral Pain Treatment market, by Indication, 2016-2027 (USD Million)
  • TABLE Latin America Visceral Pain Treatment market, by Country, 2016-2027 (USD Million)
  • TABLE Latin America Visceral Pain Treatment market, by Drug Type, 2016-2027 (USD Million)
  • TABLE Latin America Visceral Pain Treatment market, by Indication, 2016-2027 (USD Million)
  • TABLE Middle East and Africa Visceral Pain Treatment market, by Country, 2016-2027 (USD Million)
  • TABLE Middle East and Africa Visceral Pain Treatment market, by Drug Type, 2016-2027 (USD Million)
  • TABLE Middle East and Africa Visceral Pain Treatment market, by Indication, 2016-2027 (USD Million)

List of Figures

  • FIGURE Visceral Pain Treatment market segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2019
  • FIGURE Drug Type segment market share analysis, 2020 & 2027
  • FIGURE Drug Type segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Indication segment market share analysis, 2020 & 2027
  • FIGURE Indication segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Regional segment market share analysis, 2020 & 2027
  • FIGURE Regional segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE North America Visceral Pain Treatment market share and leading players, 2019
  • FIGURE Europe Visceral Pain Treatment market share and leading players, 2019
  • FIGURE Asia Pacific Visceral Pain Treatment market share and leading players, 2019
  • FIGURE Latin America Visceral Pain Treatment market share and leading players, 2019
  • FIGURE Middle East and Africa Visceral Pain Treatment market share and leading players, 2019
  • FIGURE North America market share analysis by country, 2019
  • FIGURE U.S. Visceral Pain Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Canada Visceral Pain Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Europe Visceral Pain Treatment market share analysis by country, 2019
  • FIGURE Germany Visceral Pain Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Spain Visceral Pain Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Italy Visceral Pain Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE UK Visceral Pain Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE France Visceral Pain Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Rest of the Europe Visceral Pain Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Asia Pacific Visceral Pain Treatment market share analysis by country, 2019
  • FIGURE India Visceral Pain Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE China Visceral Pain Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Japan Visceral Pain Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE South Korea Visceral Pain Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Singapore Visceral Pain Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Rest of APAC Visceral Pain Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Latin America Visceral Pain Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Latin America Visceral Pain Treatment market share analysis by country, 2019
  • FIGURE Brazil Visceral Pain Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Mexico Visceral Pain Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Argentina Visceral Pain Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Rest of LATAM Visceral Pain Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Middle East and Africa Visceral Pain Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Middle East and Africa Visceral Pain Treatment market share analysis by country, 2019
  • FIGURE Saudi Arabia Visceral Pain Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE United Arab Emirates Visceral Pain Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)